Choline Supplementation Attenuates Experimental Sepsis-Associated Acute Kidney Injury.
Choline Supplementation Attenuates Experimental Sepsis-Associated Acute Kidney Injury.
复制标题
DOI:
10.1152/ajprenal.00033.2022
复制
发表时间:
2022-07
期刊:
影响因子:
--
通讯作者:
Denise C. Hasson;Miki Watanabe-Chailland;L. Romick-Rosendale;Adeleine Koterba;Dashiell S Miner;P. Lahni;Q. Ma;S. Goldstein;P. Devarajan;Stephen W. Standage
中科院分区:
文献类型:
--
作者:
Denise C. Hasson;Miki Watanabe-Chailland;L. Romick-Rosendale;Adeleine Koterba;Dashiell S Miner;P. Lahni;Q. Ma;S. Goldstein;P. Devarajan;Stephen W. Standage
Acute kidney injury (AKI) is common in critically ill patients, and sepsis is its leading cause. Sepsis-associated AKI (SA-AKI) causes greater morbidity and mortality than other AKI etiologies, yet underlying mechanisms are incompletely understood. Metabolomic technologies can characterize cellular energy derangements, but few discovery analyses have evaluated the metabolomic profile of SA-AKI. To identify metabolic derangements amenable to therapeutic intervention, we assessed plasma and urine metabolites in septic mice and critically ill children and compared them by AKI status. Metabolites related to choline and central carbon metabolism were differentially abundant in SA-AKI in both mice and humans. Gene expression of enzymes related to choline metabolism were altered in the kidneys and liver of mice with SA-AKI. Treatment with intraperitoneal choline improved renal function in septic mice. Because septic pediatric patients displayed similar metabolomic profiles to septic mice, choline supplementation may attenuate pediatric septic AKI.